BR9908744A - Use of a culture medium - Google Patents

Use of a culture medium

Info

Publication number
BR9908744A
BR9908744A BR9908744A BR9908744A BR9908744A BR 9908744 A BR9908744 A BR 9908744A BR 9908744 A BR9908744 A BR 9908744A BR 9908744 A BR9908744 A BR 9908744A BR 9908744 A BR9908744 A BR 9908744A
Authority
BR
Brazil
Prior art keywords
culture medium
proteins
medium
cucumbers
hydrolysates
Prior art date
Application number
BR9908744A
Other languages
Portuguese (pt)
Inventor
Pierre Heimindinger
Original Assignee
Aventis Pasteur
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur, Merial Sas filed Critical Aventis Pasteur
Publication of BR9908744A publication Critical patent/BR9908744A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0043—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32651—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

<B>USO DE UM MEIO DE CULTURA<D> A invenção refere-se a um meio para crescimento e propagação virais em células cultivadas, caracterizado por ser livre de proteínas animal ou humana e compreender proteínas ou glicoproteínas extraídas de batatas ou pepinos, tendo um potencial nitrogênico e cujo peso molecular varia entre 1.000 e 200.000 Daltons, e/ou hidrolisados de extratos de plantas.<B> USE OF A CULTURE MEDIA <D> The invention relates to a medium for viral growth and propagation in cultured cells, characterized by being free of animal or human proteins and comprising proteins or glycoproteins extracted from potatoes or cucumbers, having a nitrogen potential and whose molecular weight varies between 1,000 and 200,000 Daltons, and / or hydrolysates from plant extracts.

BR9908744A 1998-03-13 1999-03-15 Use of a culture medium BR9908744A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803333A FR2775983B1 (en) 1998-03-13 1998-03-13 VIRAL PROPAGATION AND MULTIPLICATION MEDIUM AND METHOD
PCT/FR1999/000578 WO1999047648A2 (en) 1998-03-13 1999-03-15 Medium and method for viral propagation and growth

Publications (1)

Publication Number Publication Date
BR9908744A true BR9908744A (en) 2000-12-26

Family

ID=9524203

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908744A BR9908744A (en) 1998-03-13 1999-03-15 Use of a culture medium

Country Status (16)

Country Link
EP (1) EP1062324A2 (en)
JP (1) JP2002506636A (en)
KR (1) KR20010072556A (en)
CN (1) CN1301297A (en)
AU (1) AU752577B2 (en)
BR (1) BR9908744A (en)
CA (1) CA2322619A1 (en)
EA (1) EA200000934A1 (en)
FR (1) FR2775983B1 (en)
HU (1) HUP0101081A3 (en)
IL (1) IL138250A0 (en)
NZ (1) NZ506872A (en)
PL (1) PL343557A1 (en)
SK (1) SK12882000A3 (en)
TR (1) TR200002641T2 (en)
WO (1) WO1999047648A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000083657A (en) * 1998-07-13 2000-03-28 Chemo Sero Therapeut Res Inst Japanese encephalitis virus vaccine
AT409379B (en) 1999-06-02 2002-07-25 Baxter Ag MEDIUM FOR PROTEIN- AND SERUM-FREE CELL CULTURE
JP4499990B2 (en) * 2001-03-27 2010-07-14 バーテックス ファーマシューティカルズ インコーポレイテッド Compositions and methods useful for HCV infection
CA2491992A1 (en) * 2002-07-09 2004-01-15 Baxter International, Inc. Animal protein free media for cultivation of cells
GB0304799D0 (en) 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
RU2486236C2 (en) 2006-01-04 2013-06-27 Бакстер Интернэшнл Инк. Method of protein expression
JP5458536B2 (en) * 2008-09-17 2014-04-02 不二製油株式会社 Method for producing lactic acid and additive for lactic acid fermentation
CN107043739A (en) * 2017-04-24 2017-08-15 浙江美保龙生物技术有限公司 A kind of Vero cell culture solution additive and preparation method thereof, application method
CN107129963A (en) * 2017-04-24 2017-09-05 浙江美保龙生物技术有限公司 A kind of cell culture solution additives of DF 1 and preparation method thereof, application method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
FR2732347A1 (en) * 1995-03-30 1996-10-04 Bio Media Plant extract used as cell growth factor medicament with antitumoural and anticancer activity
KR20000016714A (en) * 1997-04-16 2000-03-25 페바 엔.베. Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine

Also Published As

Publication number Publication date
CN1301297A (en) 2001-06-27
TR200002641T2 (en) 2000-11-21
SK12882000A3 (en) 2001-05-10
PL343557A1 (en) 2001-08-27
WO1999047648A3 (en) 1999-11-04
IL138250A0 (en) 2001-10-31
WO1999047648A2 (en) 1999-09-23
FR2775983B1 (en) 2000-11-10
KR20010072556A (en) 2001-07-31
FR2775983A1 (en) 1999-09-17
CA2322619A1 (en) 1999-09-23
JP2002506636A (en) 2002-03-05
AU752577B2 (en) 2002-09-26
EA200000934A1 (en) 2001-02-26
HUP0101081A3 (en) 2003-04-28
HUP0101081A2 (en) 2001-07-30
EP1062324A2 (en) 2000-12-27
NZ506872A (en) 2002-03-01
AU2735299A (en) 1999-10-11

Similar Documents

Publication Publication Date Title
AU4059089A (en) In vitro propagation of embryonic stem cells
DE69024965T2 (en) DEHYDRODIDEMNIN B
AR001731A1 (en) New cellulase method to produce the vector-containing composition comprising the DNA that the host cell encodes application method
AR020735A1 (en) A PROCEDURE FOR OBTAINING A GLUCOSYLED POLYPEPTIDE FROM EUCARIOTIC CELLS
ATE153858T1 (en) LIGAND FOR THE NEW GENE PRODUCT
BR9908744A (en) Use of a culture medium
NO982810D0 (en) Continuous human skin cell lines and serum-free medium useful for their preparation
DK0549774T3 (en) Use of porous calcium carbonate as carrier material for in vitro cell cultures
FI914911A0 (en) Colostrum fraction, method for its preparation and its use as a supplement to growing media
ES2174322T3 (en) USE OF CARBOXYAMIDE POLYSYLOXANES FOR THE HYDROPHOBIZATION OF LEATHER.
DE69736858D1 (en) IMMORTAL BIRDS
DE59410132D1 (en) HUMANESCIRCULAR CYTOKIN CC-1
DE60324948D1 (en) PREPARATION FOR ITURIN A AND ITS HOMOLOGIST
ES2052883T3 (en) CULTIVATION OF CELLS OF PORK KIDNEY AND ITS USE IN THE PRODUCTION OF VACCINES.
BR9800928A (en) Cosmetic material, and, process for preparing the same.
DE69934399D1 (en) COMPLEX OF PEPTIDE AND MHC PEPTIDE ON THE SURFACE OF PHAGEN
DE69915504D1 (en) BODY HYGIENE PRODUCTS BASED ON LAPACHO EXTRACTS CONTAINING QUERCETINE, THEIR PRODUCTION AND USE
DK439086D0 (en) PROCEDURES FOR USING CELL LINES WITHOUT HUMAN CLASS II HISTOCompatibility Antigens
Terada et al. Recovery of intact membrane proteins from adherent animal cells grown in a liquid-liquid interface
TR200002555T2 (en) Methods for plant transformation and regeneration.
MX9101253A (en) MEANS FOR THE CULTIVATION OF INSECT CELLS
KUSUNOKI et al. MORPHOLOGICAL STUDY OF HUMAN THYROID PAPILLARY CARINOMA CELLS IN COLLAGEN GEL CULTURE
DE69923595D1 (en) PREPARATION OF PROTEINS
DK0925333T3 (en) Antifreeze stabilization of aqueous coatings with antifreeze proteins
KR890013189A (en) Method for preparing siconin derivative by tissue culture of branched plants

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTA A 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.